Related Experiment Video
Updated: May 9, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Approaches to Ultra-Rare Sarcomas: Definitions, Diagnostics, and Therapies.
Alessandra Merlini1, Angelo Paolo Dei Tos2, Pan Pantziarka3
1Department of Oncology, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy; Medical Oncology, San Luigi Gonzaga University Hospital, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.
Ultra-rare sarcomas, affecting 1 in a million, present unique challenges for research and treatment. This review offers insights into their complexity, global disparities, and future management strategies for clinicians and researchers.
Area of Science:
- Oncology
- Sarcoma Research
- Rare Diseases
Background:
- Ultra-rare sarcomas are defined by an incidence of 1 case per million inhabitants per year.
- Their rarity impedes the development of histotype-specific randomized controlled trials.
- Understanding these challenges is crucial for advancing patient care.
Purpose of the Study:
- To provide practical information and reference for clinicians and researchers on ultra-rare sarcomas.
- To elucidate the complexity, global treatment discrepancies, and management choices for these rare tumors.
- To highlight patient discrimination and differences in innovative agent approval.
Main Methods:
- This manuscript is a review and reference guide.
- It synthesizes existing knowledge on definitions, diagnostic challenges, and therapeutic approaches.
- It analyzes disparities in treatment and drug approval.
Main Results:
- Rarity is a significant barrier to conducting specific research studies for ultra-rare sarcomas.
- There are worldwide discrepancies in available treatment options and management strategies.
- Patients face discrimination, and innovative agents have varying approval statuses globally.
Conclusions:
- Developing a comprehensive understanding of ultra-rare sarcomas is essential for improving patient outcomes.
- Addressing global disparities and advocating for equitable access to innovative treatments is paramount.
- Future efforts should focus on collaborative research and policy changes to benefit patients with ultra-rare sarcomas.
More Related Videos
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy